Showing results (31-40 of 419) with videos related to

Sort By:
Pageof 42
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Cytokines as new treatment targets in chronic heart failureJan Kristian Damås, Lars Gullestad, Pål Aukrust
BMC Sports Science, Medicine & Rehabilitation|June 11, 2020
Effect of high-intensity interval training in young heart transplant recipients: results from two randomized controlled trialsKari Nytrøen, Katrine Rolid, Marianne Yardley, et al.
Heart & Lung : the Journal of Critical Care|August 2, 2003
A descriptive study of early nonspecific chest pain after PTCA: important area for the acute health care personnelMarit Ronnevig, Elisabeth Bjorsvik, Lars Gullestad, et al.
Scandinavian Journal of Urology and Nephrology|July 1, 1984
Effect of Ace-Inhibition on Regional Blood Flow During Acute Left Ventricular Failure in the DogChristian Hall, Lars Mørkrid, John Kjekshus
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 12, 2006
[Unexpected sudden death after percutaneous coronary intervention]Jørgen Gravning, Ashild Vege, John Kjekshus
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|May 12, 2004
Therapeutic potential of anticytokine therapy in congestive heart failurePal Aukrust, Arne Yndestad, Jan K Damås, et al.
Autoimmunity Reviews|April 28, 2004
Inflammation and chronic heart failure-potential therapeutic role of intravenous immunoglobulinPål Aukrust, Arne Yndestad, Jan Kristian Damås, et al.
JACC. Heart Failure|June 23, 2014
Effect of rosuvastatin on repeat heart failure hospitalizations: the CORONA Trial (Controlled Rosuvastatin Multinational Trial in Heart Failure)Jennifer K Rogers, Pardeep S Jhund, Ana-Cristina Perez, et al.
Circulation|November 18, 2009
Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysisJohn J V McMurray, John Kjekshus, Lars Gullestad, et al.
European Heart Journal|March 31, 2009
Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failureArne Yndestad, Linn Landrø, Thor Ueland, et al.
Pageof 42